Close Menu

NEW YORK – Rebus Biosystems, most recently known as Optical Biosystems, announced Thursday it has closed a $20 million Series B financing round, led by Illumina Ventures.

Lifecore Partners, Ncore Ventures, Xolon Invest, CTK Investments, Ray, Seegene Medical Foundation, LabGenomics, and Timefolio Asset Management joined the round.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.

National Geographic reports that nine great apes at the San Diego Zoo have been vaccinated against SARS-CoV-2.

Janet Woodcock, the acting commissioner of the US Food and Drug Administration, speaks with NPR about SARS-CoV-2 testing and vaccines in the US.

In Science this week: genetic study of kidney fibrosis implicates the SOX9-NAV3-YAP1 axis.